From surviving to thriving: cardio-oncology research, prevention and treatment ($2M)

Better treatments have increased survival rates, yet many cancer therapies can lead to significant cardiac disease years later. Cedars has established a new cardio-oncology program to identify patients at higher risk for developing cardiovascular problems, to provide appropriate surveillance, and to initiate early treatment when needed.

“Interdisciplinary collaboration between oncology and cardiology, between the bench and the bedside, is helping us to offer the best care for our patients and is leading the way for cancer survivors in Canada.”

Dr. Negareh Mousavi
Director, Cardio-oncology Program, MUHC